LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltration

BACKGROUND: The prevalence of lupus nephritis (LN) remains high despite various emerging monoclonal antibodies against with targeting systemic lupus erythematosus (SLE). Renal fibrosis is the main feature of late stage LN, and novel therapeutic agents are still needed. We previously reported that mi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Res Ther
Main Authors: Luan, Junjun, Fu, Jingqi, Chen, Chengjie, Jiao, Congcong, Kong, Weiwei, Zhang, Yixiao, Chang, Qing, Wang, Yanqiu, Li, Detian, Illei, Gabor G., Kopp, Jeffrey B., Pi, Jingbo, Zhou, Hua
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6907329/
https://ncbi.nlm.nih.gov/pubmed/31829247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-019-2044-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados